SCHEMBL6032151

SCHEMBL6032151

Cc1c(C(F)(F)F)ccc2[nH]c(Cl)nc12

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
PTGES O14684 2/20 0.39
TRPV1 Q8NER1 1/20 0.34
PDE2A O00408 2/20 0.33
RPS6KA3 P51812 1/20 0.33
CACNA1G O43497 2/20 0.32
CACNA1H O95180 2/20 0.32
CACNA1C Q13936 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
CBFB Q13951 1/20 0.31
ADRB2 P07550 1/20 0.31
POLB P06746 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
GRM4 Q14833 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17731701 0.79 NPC1 (0.46) NPC1RAB9APTGESTRPV1MEN1
SCHEMBL6031259 0.77 NPC1 (0.47) NPC1RAB9ARPS6KA3CBFBGAA
SCHEMBL1192237 0.77 NPC1 (0.50) NPC1RAB9APDE2ARPS6KA3CBFB
SCHEMBL26810956 0.73 CACNA1H (0.41) PTGESCACNA1GCACNA1HCACNA1C
SCHEMBL1128497 0.71 NPC1 (0.45) NPC1RAB9ATRPV1RPS6KA3CBFB
SCHEMBL7345385 0.71 RAB9A (0.45) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL7919226 0.69 PARP1 (0.45) PTGESMEN1KMT2APOLB
SCHEMBL7614256 0.68 NOTUM (0.31)
SCHEMBL2418541 0.68 CACNA1H (0.60) CACNA1GCACNA1HCACNA1C
SCHEMBL30822920 0.68 CACNA1H (0.60) CACNA1GCACNA1HCACNA1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1633722-A2 PREPARATION AND USE OF ARYL ALKYL ACID DERIVATIVES FOR THE TREATMENT OF OBESITY Bayer Pharmaceuticals Corporation (US) 2006-03-15 EP disclosed
WO-2004100881-A2 PREPARATION AND USE OF ARYL ALKYL ACID DERIVATIVES FOR THE TREATMENT OF OBESITY BAYER PHARMACEUTICALS CORPORATION (US) 2004-11-25 WO disclosed